Aortic valve disease with severe ventricular dysfunction: stentless valve for better recovery

Area of Science:

• Cardiovascular Surgery
• Cardiac Valve Replacement
• Echocardiography

Background:

• Stentless bioprostheses offer superior hemodynamics compared to stented valves.
• Limited data exist on stentless aortic valves for severe left ventricular dysfunction (LVEF ≤ 35%).

Purpose of the Study:

• To evaluate the benefits of stentless aortic valve implantation in patients with severe left ventricular dysfunction undergoing isolated aortic valve replacement.

Main Methods:

• Retrospective analysis of 53 patients with LVEF ≤ 35% undergoing isolated aortic valve replacement.
• Comparison between 20 patients receiving stentless valves and 33 receiving conventional valves (stented bioprostheses or mechanical).
• Analysis of factors predicting left ventricular ejection fraction (LVEF) recovery via regression analysis.

Main Results:

• No significant difference in early or late mortality between groups.
• Stentless aortic valve implantation was associated with longer aortic cross-clamp times (p=0.037).
• The stentless group demonstrated significantly better LVEF recovery (p=0.016) and a larger indexed effective orifice area (p<0.0001).
• A larger indexed effective orifice area was an independent predictor of enhanced LVEF recovery (p=0.024).

Conclusions:

• Stentless aortic valve implantation is a safe procedure for patients with severe left ventricular dysfunction.
• This approach leads to a larger indexed effective orifice area, promoting enhanced LVEF recovery.
• Despite being technically more demanding, stentless valves offer significant hemodynamic advantages.